Trexquant Investment’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Sell |
229,781
-358,636
| -61% | -$4.03M | 0.03% | 799 |
|
|
2025
Q1 | $2.69M | Sell |
588,417
-47,430
| -7% | -$217K | 0.03% | 755 |
|
|
2024
Q4 | $3.59M | Buy |
635,847
+80,345
| +14% | +$453K | 0.04% | 644 |
|
|
2024
Q3 | $2.69M | Buy |
555,502
+32,109
| +6% | +$155K | 0.03% | 698 |
|
|
2024
Q2 | $2.55M | Buy |
523,393
+360,630
| +222% | +$1.76M | 0.04% | 646 |
|
|
2024
Q1 | $2.16M | Buy |
+162,763
| New | +$2.16M | 0.04% | 621 |
|
|
2022
Q4 | – | Sell |
-21,121
| Closed | -$726K | – | 1758 |
|
|
2022
Q3 | $726K | Buy |
+21,121
| New | +$726K | 0.03% | 651 |
|